Risk tables for parkinsonism and Parkinson's disease

被引:265
|
作者
Elbaz, A
Bower, JH
Maraganore, DM
McDonnell, SK
Peterson, BJ
Ahlskog, JE
Schaid, DJ
Rocca, WA
机构
[1] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
关键词
parkinsonism; Parkinson's disease; epidemiology; lifetime risk; cumulative risk; competing risks;
D O I
10.1016/S0895-4356(01)00425-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976-1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4% for men and 3.7% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0% for men and 1.3% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [1] Parkinson's Disease and Parkinsonism
    Hayes, Michael T.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07) : 802 - 807
  • [2] Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism
    Li, Yan
    McLernon, David J.
    Counsell, Carl E.
    Macleod, Angus D.
    PARKINSONISM & RELATED DISORDERS, 2024, 118
  • [3] Risk of fracture amongst patients with Parkinson's disease and other forms of parkinsonism
    Sleeman, Isobel
    Che, Zhu Chung
    Counsell, Carl
    PARKINSONISM & RELATED DISORDERS, 2016, 29 : 60 - 65
  • [4] Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
    Zhang, Yu
    Tartaglia, Maria Carmela
    Zhan, Wang
    Ofori, Edward
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [5] Parkinsonism or Parkinson's disease unmasked by pentoxifylline?
    Serrano-Dueñas, M
    NEUROLOGIA, 2001, 16 (01): : 39 - 42
  • [6] Nigrostriatal tau pathology in parkinsonism and Parkinson's disease
    Chu, Yaping
    Hirst, Warren D.
    Federoff, Howard J.
    Harms, Ashley S.
    Stoessl, A. Jon
    Kordower, Jeffrey H.
    BRAIN, 2024, 147 (02) : 444 - 457
  • [7] Parkinson's disease, parkinsonism and aging
    Nicita-Mauro, V
    Basile, G
    Mento, A
    Epifanio, A
    Martino, G
    Morgante, L
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2002, : 225 - 238
  • [8] Neuroleptics, parkinsonism and Parkinson's disease
    Ruzicka, E
    Roth, J
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1996, 59 (03) : 131 - 133
  • [9] Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson’s disease
    Young Hee Sung
    Suk Yun Kang
    Neurological Sciences, 2022, 43 : 4797 - 4802
  • [10] Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson's disease
    Sung, Young Hee
    Kang, Suk Yun
    NEUROLOGICAL SCIENCES, 2022, 43 (08) : 4797 - 4802